OptimizeRx Corporation (OPRX) NASDAQ

16.98

+0.12(+0.71%)

Updated at August 18 04:00PM

Currency In USD

Valuation

Market Cap88.9M
Enterprise Value108.72M
P/E Ratio-31.85
PEG Ratio-0.89
Price/Sales Ratio3.01
Price/Book Ratio2.64
Enterprise/Revenue2.89
Enterprise/EBITDA290.58

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.09
Operating Margin-0.04

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.08

Income Statement

Revenue92.13M
Revenue/Share5.66
Gross Profit59.38M
EBITDA-8.9M
Net Income-20.11M
Diluted EPS-1.1

Balance Sheet

Total Cash16.59M
Total Cash/Share0.9
Total Debt3.85M
Total Debt/Equity0.03
Current Ratio2.57
Book Value Per Share6.44

Price History

52-Week Change100.95
52-Week High18.22
52-Week Low3.78
Moving Average 50 Days13.88
Moving Average 200 Days8.68

Statistics

Average Volume322,170
Shares Outstanding18.57M
% Held by Institutions63.53

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:3
Last Split DateMay 14, 2018